Cargando…
Status of the Rollout of the Meningococcal Serogroup A Conjugate Vaccine in African Meningitis Belt Countries in 2018
BACKGROUND: A novel meningococcal serogroup A conjugate vaccine (MACV [MenAfriVac]) was developed as part of efforts to prevent frequent meningitis outbreaks in the African meningitis belt. The MACV was first used widely and with great success, beginning in December 2010, during initial deployment i...
Autores principales: | Bwaka, Ado, Bita, André, Lingani, Clément, Fernandez, Katya, Durupt, Antoine, Mwenda, Jason M, Mihigo, Richard, Djingarey, Mamoudou H, Ronveaux, Olivier, Preziosi, Marie-Pierre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6822965/ https://www.ncbi.nlm.nih.gov/pubmed/31671448 http://dx.doi.org/10.1093/infdis/jiz336 |
Ejemplares similares
-
Meningococcal Meningitis Outbreaks in the African Meningitis Belt After Meningococcal Serogroup A Conjugate Vaccine Introduction, 2011–2017
por: Fernandez, Katya, et al.
Publicado: (2019) -
Spatiotemporal Analysis of Serogroup C Meningococcal Meningitis Spread in Niger and Nigeria and Implications for Epidemic Response
por: Cooper, Laura V, et al.
Publicado: (2019) -
Meningococcal Meningitis Surveillance in the African Meningitis Belt, 2004–2013
por: Lingani, Clément, et al.
Publicado: (2015) -
Introduction and Rollout of a New Group A Meningococcal Conjugate Vaccine (PsA-TT) in African Meningitis Belt Countries, 2010–2014
por: Djingarey, Mamoudou H., et al.
Publicado: (2015) -
Future Directions for Meningitis Surveillance and Vaccine Evaluation in the Meningitis Belt of Sub-Saharan Africa
por: Novak, Ryan T, et al.
Publicado: (2019)